Pharmaceutical Division
Dexamethasone Sodium Phosphate Injection IP
1 ml formulation positioned for dependable manufacturing support and global market supply.
Injectable1 mlWHO-GMP Certified
Injectable Portfolio
Global Supply
Compliance Ready
Supported through a WHO-GMP-compliant injectable manufacturing network with a focus on batch consistency, documentation readiness, and dependable international supply.
Product Details
Product Name
Dexamethasone Sodium Phosphate Injection IP
Strength / Composition
Each ml Contains:. Dexamethasone Sodium Phosphate IP Equivalent to Dexamethasone Phosphate 4 mg. Methyl Paraben IP 0.15 % w/v. Propyl Paraben IP 0.02 % w/v.
Dosage Form
1 ml
Therapeutic Application
Hormonal
Quality & Compliance
- Sourced through WHO-GMP aligned manufacturing facilities with controlled processing and batch release documentation.
- Documentation support includes COA, COPP, CTD/ACTD dossiers, stability data, and market-specific packaging information.
- Responsive commercial support for tenders, institutional procurement, and branded generic distribution across Africa, the Middle East, CIS, Latin America, and Southeast Asia.
Product Inquiry
Related Products
Disclaimer
Products offered are intended strictly for R&D, registration and/or export purposes only. The responsibility for ensuring that the product does not infringe any third-party patent or intellectual property rights in the destination country rests solely with the buyer. Products will not be supplied to countries where patent laws are in force, unless permitted by law or the buyer assumes all responsibility.